Latest News about QURE
Recent news which mentions QURE
Stocks That Hit 52-Week Lows On Friday
March 05, 2021
From Benzinga
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
March 05, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 04, 2021
From Benzinga
10 Biggest Price Target Changes For Tuesday
March 02, 2021
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
February 19, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 18, 2021
From Benzinga
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
February 18, 2021
From Benzinga
No Safety Concerns Observed In Uniqure's Early-Stage Huntington's Gene Therapy Study, DSMB Says
February 08, 2021
Tickers
QURE
From Benzinga
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
December 26, 2020
From Benzinga
82 Biggest Movers From Yesterday
December 22, 2020
From Benzinga
Mid-Afternoon Market Update: Dow Turns Positive; uniQure Shares Slide
December 21, 2020
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 21, 2020
From Benzinga
Mid-Day Market Update: Crude Oil Down 4%; 500.com Shares Spike Higher
December 21, 2020
From Benzinga
55 Stocks Moving In Monday's Mid-Day Session
December 21, 2020
From Benzinga
Mid-Morning Market Update: Markets Open Lower; FactSet Research Beats Q1 Estimates
December 21, 2020
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 21, 2020
From Benzinga
UniQure Plunges As FDA Slaps Clinical Hold On Hemophilia B Gene Therapy Study On Possible Liver Cancer Link
December 21, 2020
Tickers
QURE
From Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
December 06, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For October 23, 2020
October 23, 2020
From Benzinga
The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs
October 16, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 15, 2020
From Benzinga
The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac
September 30, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 29, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For August 25, 2020
August 25, 2020
From Benzinga
Is Biomarin's Disaster Bad News for Your Gene Therapy Stocks?
August 22, 2020
From Motley Fool
Benzinga's Top Upgrades, Downgrades For July 31, 2020
July 31, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.